期刊文献+

甲状腺球蛋白测定和^(131)I-全身显像在综合治疗分化型甲状腺癌随访中的价值 被引量:5

The clinical value of serum thyroglobulin combined with Iodine-131 whole body scanning in the follow-up of differentiated thyroid cancer after thyroid ablation
下载PDF
导出
摘要 目的:探讨血清甲状腺球蛋白(Tg)和131I-全身显像(131I-WBS)联合检查在分化型甲状腺癌(differentiatedthyroidcarcinoma,DTC)患者手术+131I治疗后随访中的临床价值。方法:55例DTC患者术后3~4周行131I清除残余甲状腺组织治疗(以下简称"清甲"),131I治疗前及随访时用RIA法各测定1次血清Tg,同时口服131I111~185MBq(平均133.8MBq)48h后,和(或)口服治疗剂量131I3.7~5.55GBq(平均4.5GBq)5~7d后做全身显像。结果:24例经临床证实有复发或转移的DTC患者中,11例(45.8%)Tg>10ng/mL,21例(87.5%)131I-WBS阳性,只有8例(33.3%)患者Tg和131I-WBS同时阳性。结论:DTC经手术+131I治疗后,常规进行Tg测定和131I-WBS检查,对尽早发现复发或有无转移、决策131I治疗方案以及评估131I疗效具有重要的临床价值。 Objective To investigate the clinical value of serum thyroglobulin(Tg) measurements combined with Iodine-131 (131I) whole body scans (WBS) in the follow-up of differentiated thyroid carcinoma (DTC) after thyroid ablation.Methods Fifty-five patients were enrolled in the study.A diagnostic 131I-WBS was performed 48h after administration of 111 ~ 185 MBq 131I in patients with post-thyroidectomy and 131I ablated treatment.Subsequently,therapeutic 131I-WBS were performed 5 ~ 7 days after administration of 3.7 ~ 5.55 GBq 131I.Serum Tg and anti-thyroglobulin autoantibody were measured in all patients.Results In 11 of 24 patients (45.8%) with relapsed or metastatic differentiated thyroid carcinoma,the serum Tg values increased over normal range.In 21 patients (87.5%),the results of 131I-WBS were positive.Among these patients,both abnormally radioactive uptake in 131I-WBS and elevation of serum Tg were found in only 8 patients (33.3%).Conclusions Routine serum Tg measurement and 131I-WBS in patients with DTC after thyroidectomy is essential.It is of great clinical value in early detecting metastatic nidus,optimizing the treatment protocol and evaluating the curative effect.
作者 廖宁
出处 《实用医学杂志》 CAS 北大核心 2011年第19期3505-3507,共3页 The Journal of Practical Medicine
基金 广西医疗卫生重点科研课题(编号:重 2000985)
关键词 甲状腺肿瘤 放射疗法 放射性核素显像 甲状腺球蛋白 Thyroid neoplasms Radiotherapy Radionuclide imaging Thyroglobulin
  • 相关文献

参考文献7

二级参考文献16

  • 1管昌田.分化型甲状腺癌术后复发和转移的早期诊断及处理[J].国外医学(放射医学核医学分册),1995,19(4):156-161. 被引量:12
  • 2王辉,付宏亮,吴真,李佳宁,杜学亮,邹仁健,吴靖川.血清HTg测定与^(131)I全身显像在分化型甲状腺癌患者^(131)I治疗随访中的临床价值[J].放射免疫学杂志,2007,20(1):5-7. 被引量:8
  • 3Pacini F, Agate L, Elisei R. Outcome of differentiated thyroid cancer with detectable serum Tg and negative ^131I whole body scan :comparison of patients treated with high ^131I activities versus untreated [ J ]. J Clin Endocrinol Metab ,2001,86 ( 9 ) :4092-4097. 被引量:1
  • 4Mansi L, Moncayo R, Cuccurullo V, et al. Nuclearmedicine in diagnosis,staging and follow-up of thyroid cancer [J]. Q J Nucl Med Mol Imaging,2004,48 ( 2 ) : 82 -95. 被引量:1
  • 5Ong S, Ng D, Sundram F. Initial experience in use of fluorine-8-fluoro- deoxyglueose positron emission tomography/eomputed tomography in thyroid carcinoma with elevated serum thyroglobulin but negative iodine-131 whole body scans [ J ]. Singapore Med J, 2005,46 ( 6 ) : 297- 3011. 被引量:1
  • 6Richard J, Jajin T, Martin F, et al. Is the Serum Thyroblobulin Response to Recombinant Human Thyrotropin Sumcient, by It self, to Monitor for Residual Thyroid Carcinoma [ J ]. J Cliu Endocrinol Metab, 2002,87 ( 7 ) : 3242 -3247. 被引量:1
  • 7Charles P, Barsano MD, Consuelo S, et al. Serum HTg in the mangement of patients with thyroid cancer. Arch Intern Med. 1982,14(2) :763. 被引量:1
  • 8Frank G, Eva P, Hans B, et al. Redifferentiation therapy with retinoic acid in follicular thyroid cancer. J Nucl Med. 1998,39(3):1555. 被引量:1
  • 9Bajen MT, Mane S, Munoz A, et al. Effect of a diagnostic dose of 185 MBq 131 Ⅰ on postsurgical thyroid remnants. J Nucl Med. 2000,41( 12 ) :2038. 被引量:1
  • 10李少林.核医学[M]:5版[M].北京:人民卫生出版社,2002.343-348. 被引量:5

共引文献20

同被引文献55

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部